Thomas S. Wingo

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

Erik C. B. Johnson, Eric B. Dammer, Duc M. Duong et al. · Nature Medicine · 2020 · 993 citations · Full text

Neuroimaging Biomarkers, Neurodegenerative Diseases, Alzheimer's Disease +11

Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level

Erik C. B. Johnson, Kathleen Carter, Eric B. Dammer et al. · Nature Neuroscience · 2022 · 574 citations · Full text

A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease

Nicholas T. Seyfried, Eric B. Dammer, Vivek Swarup et al. · Cell Systems · 2016 · 511 citations · Full text

Neuroimaging Biomarkers, Neurodegenerative Diseases, Molecular Neuroscience +15

Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study

Eric M. Reiman, Joseph F. Arboleda‐Velásquez, Yakeel T. Quiroz et al. · Nature Communications · 2020 · 464 citations · Full text

Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis

Aliza P. Wingo, Yue Liu, Ekaterina S. Gerasimov et al. · Nature Genetics · 2021 · 380 citations · Full text

Proteomic Technology, Neurodegenerative Diseases, Alzheimer's Disease +13